Correction: Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans
2025; Springer Science+Business Media; Linguagem: Inglês
10.1007/s00125-025-06372-z
ISSN1432-0428
AutoresElise Wreven, María Soledad Ruiz de Adana, Stéphan Hardivillé, Valéry Gmyr, Julie Kerr–Conte, Mikaël Chetboun, Gianni Pasquetti, Nathalie Delalleau, Julien Thévenet, Anaïs Coddeville, María José Vallejo Herrera, Liad Hinden, Inmaculada Concepción Benavides Espínola, Mireia Gómez Duro, Lourdes Sánchez‐Salido, Francisca Linares, Francisco J. Bermúdez‐Silva, Joseph Tam, Caroline Bonner, Josephine M. Egan, Gabriel Olveira, Natalia Colomo, François Pattou, Isabel González‐Mariscal,
Tópico(s)Diabetes and associated disorders
Referência(s)